DISCOVER MORE
Our Corporate Access Portal serves as a tool to inform and engage investors by providing in-depth investor profiles for selected public companies and aims to facilitate meaningful one-on-one meetings between investors and company executives.
Investors can unlock captivating fireside chats and company webcasts; discover insightful KOL panels with public company executives and industry experts; and stay informed with real-time stock data, SEC filings, press releases and more.
Explore our Featured Companies and schedule your one-on-one meetings today!
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are shaping adoption, and where investors may find compelling opportunities across the healthcare IT landscape.
RECENT NEWS
Biofrontera Announces FDA Filing Acceptance of Supplemental New Drug Application for Ameluz® PDT in Superficial Basal Cell Carcinoma
Prescription Drug User Fee Act (PDUFA) target action date set for September 28, 2026If approved, Ameluz® would be the first and only PDT...
Comstock Inc. Featured on Water Tower Research Small-Cap Spotlight Podcast
VIRGINIA CITY, Nev., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Comstock Inc. (NYSE: LODE) ("Comstock" or the "Company") and its subsidiary, Comstock...
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
The Company is in Advanced Stages of Commercial U.S. Partnership Discussions for D-PLEX Positive FDA Pre-NDA Feedback Supports Rolling NDA...
RECENT EVENTS
Aytu BioPharma (AYTU) Fireside Chat
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system...
Cadrenal Therapeutics (CVKD) Fireside Chat
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is developing differentiated products designed to bridge critical gaps in current acute and chronic...
Alpha Tau (DRTS) Fireside Chat
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into...
